It's a great source for the production
of high-volume recombinant
therapeutic proteins in the white of
transgenic chicken eggs.
A transgenic
production system
that meets the
industry’s needs
for:
An effectively priced alternative that:
  • Increases your flexibility,
  • Is truly scalable,
  • Improves your time to market,
  • Lowers your capital requirements, and thus
  • Improves your bottom line.
Avian Transgenics Provide:
Benefits:
Rapid gestation and development times
Chickens mature and lay eggs 6 months after hatching
Minimal development costs
Inexpensive specific pathogen free “SPF” animals/eggs; simple husbandry
Prolific protein production
On average, one egg per day; 21 per month; 252 per year from a single hen
Post-translation processing
Similarity with human, ability to glycosylate and phosphorylate
Total containment/flock assurance
Chickens can be housed in controlled health screened facilities
Existing regulatory experience
SPF eggs used for vaccine production
ABOUT TRANXENOGEN I WHY AVIAN TRANSGENICS I INVESTOR RELATIONS I ANNUAL REPORT
NEWS CENTER I CAREERS I CONTACT US I DIRECTIONS

TRANXENOGEN, INC. • PO BOX 21 • NORTHBORO, MA. 01532 • 508 842 5036

© COPYRIGHT TRANXENOGEN, INC. 2002